Rare diseases
Investigational molecules
Locations
Back to Italy1 231 clinical trials in Pozzuoli, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery
ItalyStudy of CFT1946 alone and with trametinib or cetuximab in patients with BRAF-V600 mutant solid tumors who have received standard treatment
ItalyStudy of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer
ItalyStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer
ItalyStudy on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant
ItalyStudy on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder
ItalyStudy of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer
ItalyStudy on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension
ItalyStudy on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B
ItalyStudy of ZN-c3, Encorafenib, and Cetuximab for Adults with Metastatic Colorectal Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Località la Schiana, Pozzuoli is strongly focused on cancer research, with studies examining how to improve treatment options for several advanced solid tumors. The main goal is to test new therapeutic strategies and refine existing combinations for better disease control and patient outcomes.
These studies are exploring more effective ways to slow progression, overcome treatment resistance, and improve survival in patients with advanced neoplasms.
Several trials in this site concentrate on digestive system cancers, especially advanced colorectal cancer. Research is centered on evaluating treatment effectiveness and finding better options for patients whose disease has already progressed or carries specific genetic changes.
Across these studies, the focus is on improving tumor response, extending disease control, and identifying which patients may benefit most from targeted treatment approaches.
This research landscape also includes therapeutic techniques aimed at improving how treatments are delivered and how response is monitored. The trials are not only testing active therapies, but also looking for better ways to understand resistance, safety, and treatment benefit in real-world patients.
In this part of the research portfolio, investigators in Pozzuoli are helping shape more precise and patient-centered cancer care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
